TARGET Post-Approval Study
Completed
Conditions studied: Complex Regional Pain Syndrome (CRPS)
In brief
The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium and Proclaim Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.
Key facts
- Study ID
- NCT02800863
- Run by
- Abbott Medical Devices
- People needed
- 426
- Starts
- 2016-08-23
- Expected to finish
- 2021-09-23
- Last updated by the study team
- 2024-07-08
Who can join
Age: 22 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject is male or female between ≥ 22 and ≤ 75 years of age.
- Subject has moderate to severe chronic intractable pain of the lower limbs resulting from Complex Regional Pain Syndrome (CRPS) types I or II.
- Subject has a baseline Visual Analogue Scale (VAS) of ≥ 60 mm for overall pain at the time of the baseline assessment.
- Subject is willing and able to comply with the study requirements.
- Subject is able to provide written informed consent.
You may not qualify if…
- Subject has an active implantable medical device including but not limited to cardiac pacemakers and cardiac defibrillators.
- Subject is currently involved in medically related litigation, including workers compensation.
- Subject has a life expectancy of less than one year.
- Subject is pregnant or of child bearing potential and not using adequate contraception as determined by the investigator.
- Subject has, or plans to have, a spinal cord stimulation system or infusion pump system implanted.
- Subject has, or plans to have, a peripheral nerve stimulation system (PNS) or peripheral nerve field stimulation system (PNfS) implanted.
- Subject is considered to be a poor surgical or study candidate, which may include, but is not limited to the following: any medical, social, or psychological problem that could complicate the implant procedure and/or recovery from the implant procedure or could complicate the required procedures and evaluations of the study in the judgment of the investigator.
Where it is running
- Arizona Pain Specialists — Scottsdale, Arizona, United States
- Spanish Hills Interventional Pain Specialists — Camarillo, California, United States
- California Orthopedics & Spine — Larkspur, California, United States
- Loma Linda University Hospital — Loma Linda, California, United States
- VA Loma Linda Healthcare System — Loma Linda, California, United States
- University of California - San Francisco — San Francisco, California, United States
- Orthopedic Pain Specialists — Santa Monica, California, United States
- Summit Pain Alliance Inc. — Santa Rosa, California, United States
- Pacific Research Institute — Santa Rosa, California, United States
- Front Range Pain Medicine — Fort Collins, Colorado, United States
- Coastal Orthopedics & Sports Medicine Southwest FL — Bradenton, Florida, United States
- Holy Cross Hospital — Fort Lauderdale, Florida, United States
- University of Florida - Department of Anesthesia — Gainesville, Florida, United States
- Florida Pain Institute — Merritt Island, Florida, United States
- Better Health Clinical Research — Newnan, Georgia, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Goodman Campbell Brain & Spine — Indianapolis, Indiana, United States
- Kansas University Medical Center — Kansas City, Kansas, United States
- Ochsner Medical Center — New Orleans, Louisiana, United States
- Nura — Edina, Minnesota, United States
- Twin Cities Pain Clinic — Edina, Minnesota, United States
- Advanced Pain Care — Henderson, Nevada, United States
- Nevada Advanced Pain Specialists — Reno, Nevada, United States
- Ainsworth Institute of Pain Management — New York, New York, United States
- The Spine & Pain Institute of New York — Staten Island, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.